Healthy Participant: Clinical Trials

9 completed, 1 recruiting. 10 Phase 1.

By phase and status

Phase	Trials	Status
Phase 1	10	Completed 9, Recruiting 1

Follow Healthy Participant: new trials by email Literature Review of Healthy Participant trials Research Report on Healthy Participant

Trials (filtered) newest first · largest first

All 10 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

Trial	Phase	Status	Sponsor	Enrollment	Start	Updated
A Study to Learn About How Different Forms of Study Medicine Prifetrastat Are Taken Up Into the Blood in Healthy Adults prifetrastat Reference, prifetrastat Test 1, prifetrastat Test 2 - Healthy Participant	Phase 1	Recruiting	Pfizer	32	2026-07-14	2026-07-23
A Study to Learn if a Medicine Called Itraconazole Changes How the Body Processes the Study Medicine PF-08642534 in Healthy Adults. PF-08642534, Itraconazole - Healthy Participant	Phase 1	Completed	Pfizer	14	2026-05-05	2026-08-21
A Study to Learn About How the Body Processes the Study Medicine Called PF-07328948 in Healthy Chinese Adults PF-07328948 - Healthy Participant	Phase 1	Completed	Pfizer	10	2026-03-02	2026-04-23
A Study to Learn How the Study Medicine Called Ibuzatrelvir is Taken up Into the Blood in Healthy Chinese Adults Ibuzatrelvir - Healthy Participant	Phase 1	Completed	Pfizer	12	2025-10-16	2026-01-07
A Study to Compare Two Tablet Formulations of Study Medicine Atirmociclib in Healthy Participants PF-07220060 - Healthy Participant	Phase 1	Completed	Pfizer	35	2025-08-14	2026-04-20
A Study to Learn How the Study Medicine Called Etrasimod is Taken up Into Blood and Breastmilk of Healthy Breastfeeding Women Etrasimod - Healthy Participant	Phase 1	Completed	Pfizer	8	2025-08-07	2026-10-20
Drug-Drug Interaction Study of Itraconazole With GST-HG171/Ritonavir in Healthy Participants GST-HG171/Ritonavir, Itraconazole - Healthy Participant	Phase 1	Completed	Fujian Akeylink Biotechnology Co., Ltd.	12	2023-05-12	2023-10-17
A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of DNL919 in Healthy Participants DNL919, Placebo - Healthy Participant	Phase 1	Completed	Denali Therapeutics Inc.	47	2022-07-14	2023-08-16
Drug-Drug Interaction Study Assessing Effect of Itraconazole on PF-07321332/Ritonavir in Healthy Participants PF-07321332/ritonavir, Itraconazole - Healthy Participant	Phase 1	Completed	Pfizer	12	2021-07-20	2023-07-13
Drug-Drug Interaction Study Assessing Effect of Carbamazepine on PF-07321332 Boosted With Ritonavir PF-07321332/ritonavir, Carbamazepine, PF 07321332/ritonavir - Healthy Participant	Phase 1	Completed	Pfizer	12	2021-07-15	2023-10-10

Narrower conditions

COVID-19 (1)

Broader conditions

Coronaviridae Infections (1)  ·  Coronavirus Infections (1)  ·  Infections (1)  ·  Lung Diseases (1)  ·  Nidovirales Infections (1)  ·  Pneumonia (1)  ·  Pneumonia, Viral (1)  ·  RNA Virus Infections (1)  ·  Respiratory Tract Diseases (1)  ·  Respiratory Tract Infections (1)  ·  Virus Diseases (1)

Interventions

Itraconazole (3)  ·  Ritonavir (2)  ·  nirmatrelvir and ritonavir drug combination (2)  ·  Carbamazepine (1)  ·  etrasimod (1)

Sponsors

Pfizer (8)  ·  Denali Therapeutics Inc. (1)  ·  Fujian Akeylink Biotechnology Co., Ltd. (1)

Countries

Belgium (3)  ·  China (3)  ·  United States (3)  ·  Netherlands (1)

Top investigators

Ana-Claire Meyer, MD (1)

Results publications

PMID 40145953, PMID 42112804, PMID 9812178

NIH funding

2025 (1)